Treating COVID-19: A pharmaceutical executive’s view
McKinsey
MAY 27, 2020
Cedric Francois, the CEO of pharmaceutical company Apellis, discusses possible approaches to treating COVID-19 patients.
Pharmaceutical Related Topics 
How to improve your life with pharmaceuticals
Penelope Trunk
FEBRUARY 22, 2012
When I was 27, why was I not finding fun pharmaceuticals to improve my wellbeing? Judge your pharmaceutical choices by deciding if you attract good people when you are on the medication. At 9:30 she felt a tightening in her stomach and a rush in the front of her head. At 9:50 she called me.
Pharmaceutical 
103
103 Join 36,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Webinars
The Memory Edge: Outlearn, Outperform, Outlast
Interactive Webinar: Recurring Giving Events That Keep on Giving
Trending Sources
First-time launchers in the pharmaceutical industry
McKinsey
FEBRUARY 12, 2021
Increasingly, small biopharmaceutical companies are launching their new drugs themselves rather than relying on large pharma companies to do it for them. How can they get it right the first time?
Pharmaceutical 134
134 
A ‘GOLD standard’ in brand growth for Japan’s pharmaceutical market
McKinsey
SEPTEMBER 17, 2020
Our GOLD standard will help transform your pharmaceutical brand and achieve accelerated growth.
Can a Japanese pharmaceutical become a social innovator?
McKinsey
MARCH 2, 2021
Santen CIO Minori Hara explains how IT is enabling the ophthalmological company to deliver a holistic sense of well-being around eye health.
Pharmaceutical 117
117 
Advancing real-world evidence for pharmaceutical companies in Japan
McKinsey
JULY 21, 2022
Pharma companies in Japan have an opportunity to obtain value from real-world evidence using advanced analytics and to better ensure patient outcomes.
Pharmaceutical 120
120 Pharmaceutical 120
120 
Four ways pharma companies can make their supply chains more resilient
McKinsey
SEPTEMBER 23, 2021
Pharmaceutical supply chains have become global and complex. With more outsourcing, new modalities, and novel ways to reach patients, it’s critical to ensure that they can withstand shocks.
Pharmaceutical 123
123 
What’s behind the pharmaceutical sector’s M&A push
McKinsey
OCTOBER 11, 2018
There are lessons for other industries in the way pharma companies use mergers to innovate, work more efficiently, and bolster product portfolios.
Pharmaceutical 106
106 
HR Challenges in the Pharmaceutical Industries
Vantage Circle
MAY 10, 2021
All of which will imply how the pharmaceutical industry is likely to conduct its business in the near future. With the constant layoffs, corporate mergers and acquisitions in the pharmaceutical market, and rise in the compensation standards, many businesses have also adopted an outsourcing business model. Development in Technology.
Treating rare diseases: How digital technologies can drive innovation
McKinsey
FEBRUARY 27, 2023
Pharmaceutical companies are using recent advances in digital technologies to improve care strategies and provide hope for rare disease patients across thousands of different rare diseases.
Pharmaceutical 125
125 
Developing pharmaceutical launch leaders and company-wide capabilities at scale
McKinsey
AUGUST 4, 2022
By building certain functional and leadership skills, pharma companies can not only improve the odds of a successful launch but also strengthen their organizations for the future.
Pharmaceutical 104
104 
Designing an agile transformation in pharma R&D
McKinsey
JULY 23, 2019
Pharmaceutical companies are increasingly turning to the concept of agility to help them transform their R&D functions.
Pharmaceutical 111
111 
Improving patient adherence through data-driven insights
McKinsey
DECEMBER 15, 2018
A McKinsey study points to areas pharmaceutical companies can address to combat this long-standing industry issue. When patients fail to follow prescribed medical regimens, outcomes suffer.
Pharmaceutical 111
111 
The race to create a vaccine: A conversation with Frank D’Amelio
McKinsey
DECEMBER 10, 2021
The CFO of the pharmaceutical company talks about what it took to develop a COVID-19 vaccine.
Pharmaceutical 109
109 Pharma’s digital Rx: Quantum computing in drug research and development
McKinsey
JUNE 18, 2021
Pharmaceutical companies should reflect on their strategic stance to this promising new technology now. Quantum computing’s ability to simulate larger, more complex molecules could be game changing.
Pharmaceutical 109
109 
Health equity: A framework for the epidemiology of care
McKinsey
MARCH 21, 2022
Pharmaceutical and life sciences companies can unlock new opportunities, help underserved patients, and build a cycle of trust.
Pharmaceutical 104
104 Pharmaceutical 104
104 
Making quality assurance smart
McKinsey
JANUARY 29, 2021
Pharmaceutical and medtech companies can dramatically improve quality assurance processes by applying a ‘smart quality’ lens and cutting-edge technologies.
Pharmaceutical 104
104 
Bioelectronics ‘jump-start’ the next wave of device therapeutics
McKinsey
OCTOBER 4, 2019
Blurring the lines between pharmaceuticals and medical technology, cybermedicine has the potential to become a pillar of medical treatment and play a key role in the future of medtech innovation.
Pharmaceutical 105
105 
Shaking up the value chain
McKinsey
AUGUST 16, 2018
Data and digitization are creating a growing array of value-creation choices in industries as diverse as pharmaceuticals, mining, and energy.
Pharmaceutical 111
111 Should sub-Saharan Africa make its own drugs?
McKinsey
JANUARY 11, 2019
A comprehensive analysis of the business, economic, and public-health impact finds the potential for local production of pharmaceuticals to be a mixed bag.
Pharmaceutical 111
111 
How Precision Medicine Will Transform the Pharmaceutical and Healthcare Industries
Strategy+Business
FEBRUARY 22, 2018
And although the pharmaceutical and healthcare industries know this is the way forward, they face some significant hurdles. Precision medicine combines business opportunities with clinical health benefits.
Ready for launch: Reshaping pharma’s strategy in the next normal
McKinsey
DECEMBER 15, 2020
As pharmaceutical companies reshape their commercial models to prepare for the uncertainties ahead, personalization and digital enablement will be crucial to launch success in the new environment.
Pharmaceutical 100
100 
Developing a customer-centric approach to rare conditions
McKinsey
SEPTEMBER 20, 2022
Roche Pharmaceuticals’ approach to rare conditions highlights industry efforts to make a difference for patients, their caregivers, and healthcare professionals.
Embedding ‘smart quality’ culture and capabilities in the organization
McKinsey
JANUARY 10, 2022
Pharmaceutical and medical-device companies can get the most value from “smart quality” processes enabled with new technologies by adopting a holistic approach to building culture and capabilities.
How to succeed as a chief digital officer in pharma
McKinsey
MARCH 10, 2017
We spoke to ten digital leaders at global pharmaceutical companies to understand how they focus their efforts. The life-sciences industry is embracing digital to unlock innovation.
Pharmaceutical 106
106 Pharmaceutical 106
106 
CROs and biotech companies: Fine-tuning the partnership
McKinsey
JUNE 9, 2022
Emerging biotechnology companies are less satisfied than large pharmaceutical companies with their contract research organizations (CROs). How can CROs raise their game with this key segment?
Pharmaceutical 104
104 Pharmaceutical 104
104 Unleashing the power of entrepreneurship in science
McKinsey
DECEMBER 6, 2016
A partner of venture-capital firm Atlas Venture, Bruce Booth, explains how investment assists pharmaceutical innovation.
Data Analytics and Healthcare Innovation: Insights from Najat Khan
Correlation One
APRIL 7, 2022
of the Janssen Pharmaceutical Companies of Johnson & Johnson to learn more about data and healthcare innovation. Meet Najat Khan, Ph.D.
Healthcare 98
98 
The hidden value of improved capital-expenditure management in pharma
McKinsey
AUGUST 13, 2019
Pharmaceutical companies can reap huge rewards from the hundreds of smaller projects they manage, not just from the occasional big one. Thinking about value, not just costs, is key.
From bench to bedside: Transforming R&D labs through automation
McKinsey
MARCH 8, 2023
Laboratory technology has been a steady runner in the world of pharmaceuticals, rather than a racing star—until now. A series of innovations points toward exponential gains in R&D productivity.
How Asia’s largest pharma is leveraging its values to navigate the COVID-19 crisis
McKinsey
JULY 31, 2020
Christophe Weber, CEO of Takeda Pharmaceuticals, discusses challenges to globalization, principles in the face of crises, and new opportunities when companies pull together.
Voices of CEO excellence: Merck’s Ken Frazier
McKinsey
JUNE 12, 2023
The former CEO and executive chairman of the pharmaceutical company offers candid reflections on how crises tested his commitment to values—both Merck’s and his own.
Roche’s Infinity model: Helping to transform the lives of patients with rare diseases
McKinsey
JULY 15, 2021
Anne Nijs explains how the rare-disease group at Roche Pharmaceuticals pioneered a new model that puts the patient experience at the center of healthcare innovation and delivery.
A new prescription for M&A in pharma
McKinsey
SEPTEMBER 16, 2020
Adopting a through-cycle approach to deal making in the wake of the COVID-19 pandemic can position pharmaceutical companies for greater success in the next normal.
Appreciating Differences: Leveraging Innovation in Cross-cultural Work Environments
International Coach Academy
JUNE 22, 2022
Take companies in the global pharmaceutical industry as an example. 2020), Cultural diversity drives innovation: modeling in the global pharmaceutical industry , International Journal of Innovation Science, Vol. Then, together the crew can create values based on the conversation and increase mutual understanding. Jones et al.,
Pharmaceutical 208
208 
Innovating at the speed of the 21st century in pharmaceuticals
McKinsey
OCTOBER 27, 2017
The CEO of Eli Lilly offers perspectives on accelerating change in the industry.
How new biomolecular platforms and digital technologies are changing R&D
McKinsey
JULY 31, 2018
By going digital, biotech pioneers with promising biomolecular platforms are improving drug discovery and development—and changing the pharmaceutical industry.
Thermo Fisher Scientific CEO Marc Casper on provisioning the front lines in the pandemic
McKinsey
MAY 20, 2020
Governments, healthcare providers, and pharmaceutical companies are battling COVID-19 on different fronts. Thermo Fisher Scientific is at the nexus of all of these endeavors.
Change in the Japanese pharmaceutical market: Cradle of innovation or grave of corporate profits?
McKinsey
SEPTEMBER 1, 2018
Understanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients.
Bringing an animal health business into the fold
McKinsey
AUGUST 3, 2018
Two senior Boehringer Ingelheim executives, Joachim Hasenmaier and Felix Gutsche, discuss the global pharmaceutical company’s deal with Sanofi to acquire its animal health business.
How pharma companies can better understand patients
McKinsey
MAY 4, 2016
Here’s how pharmaceutical companies can better understand the way people make decisions about their care. Consumers have access to more healthcare information than ever.
‘Stay grounded, stay humble’: Sanofi CEO Paul Hudson
McKinsey
JANUARY 11, 2023
In the wake of the COVID-19 pandemic, one of the first non-French leaders of the pharmaceutical company Sanofi explains cultural transformations, the growth of AI in decision making, and how he stays humble.
Implementing a two-invoice system in China’s MedTech market
McKinsey
MAY 5, 2017
The country is rolling out a new approach to pharmaceutical distribution. What can medical-device companies expect, and how should they prepare?
s+b Trend Watch: The Coming Digital Healthcare Landscape
Strategy+Business
MAY 11, 2014
Looking toward the future, pharmaceutical companies and other stakeholders will adopt existing technologies and develop new ones, creating a more connected digital healthcare ecosystem.' Doctors and patients are starting to use digital tools to manage healthcare more efficiently.
Healthcare 57
57 
Let's personalize your content